Immunocore Rating A · Worker

Immunocore is a biotechnology company focused on the development of T cell receptor (TCR) immunotherapies. The company researches, develops, and delivers immunomodulating medicines designed to treat cancer, infectious diseases, and autoimmune conditions.

Using its proprietary ImmTAX technology, Immunocore creates bispecific T cell receptor therapies that activate or tune the immune system to recognise and destroy diseased cells. Its pipeline includes therapies targeting solid tumors, such as its established treatment for metastatic uveal melanoma, as well as preclinical and clinical research programs spanning from laboratory discovery to patient delivery.